Half-year report · Q2
4572.TEDINET S100U5Y7
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥316m | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Revenue | ¥1.6bn | 2023-01-01 → 2023-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥501m | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Operating income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Operating income | −¥864m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Ordinary income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥1.1bn | 2023-01-01 → 2023-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥868m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥869m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥886m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Net income | −¥886m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Total assets | ¥3.7bn | at 2024-06-30 | Cons. | Assets |
| Total assets | ¥4.3bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥4.6bn | at 2023-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥470m | at 2024-06-30 | Cons. | Liabilities |
| Total liabilities | ¥472m | at 2023-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.2bn | at 2024-06-30 | Cons. | Net assets |
| Net assets / equity | ¥3.9bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥4.1bn | at 2023-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.0bn | at 2024-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.0bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.9bn | at 2023-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.7bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2022-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥222m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.7bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥939m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥7m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11m | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥279m | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.2bn | 2023-01-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-63.25 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-68.62 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-53.81 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 87.2% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.1% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.9% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥1.1bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥316m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥316m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥24m |
| jpcrp040300-q2r_E00987-000Drug Discovery Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥1.0bn |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥501m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥501m |
| jpcrp040300-q2r_E00987-000Drug Discovery Support Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥169m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 417
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss attributable to owners of parent | Prior1YTDDuration | -885608000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | -1094118000 | JPY |
| Profit loss | Prior1YTDDuration | -885608000 | JPY |
| Profit loss | CurrentYTDDuration | -1094118000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -340000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -425000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | -615000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 27374000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 25174000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 40699000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 24217000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 67649000 | JPY |
| Comprehensive income | Prior1YTDDuration | -861390000 | JPY |
| Comprehensive income | CurrentYTDDuration | -1026469000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | -861390000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -1026469000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | － | JPY |
| Income before income taxes | Prior1YTDDuration | -869389000 | JPY |
| Income before income taxes | CurrentYTDDuration | -1091384000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 16602000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 15477000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 984000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 4228000 | JPY |
| Interest income ope cf | Prior1YTDDuration | -84000 | JPY |
| Interest income ope cf | CurrentYTDDuration | -2543000 | JPY |
| Dividends income ope cf | Prior1YTDDuration | -211000 | JPY |
| Dividends income ope cf | CurrentYTDDuration | -219000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 1695000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 1726000 | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration | 22045000 | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration | 16908000 | JPY |
| Stock issuance cost ope cf | Prior1YTDDuration | 4966000 | JPY |
| Stock issuance cost ope cf | CurrentYTDDuration | 23109000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -12264000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -11257000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -4462000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 692991000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -21386000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -7335000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -1962000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -1200000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -97373000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | 63192000 | JPY |
| Decrease increase in advance payments ope cf | Prior1YTDDuration | 1964000 | JPY |
| Decrease increase in advance payments ope cf | CurrentYTDDuration | 70312000 | JPY |
| Other net ope cf | Prior1YTDDuration | 39957000 | JPY |
| Other net ope cf | CurrentYTDDuration | 11369000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | -918919000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -214624000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |